A PHASE-II TRIAL OF BISANTRENE (CL216,942) IN REFRACTORY EPITHELIAL OVARIAN-CANCER

被引：0
|
作者：
KAVANAGH, JJ
GERSHENSON, DM
SAUL, PB
COPELAND, LJ
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GYNECOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CHEMOTHERAPY RES,HOUSTON,TX 77030
来源：
GYNECOLOGIC ONCOLOGY | 1986年 / 23卷 / 01期
关键词：
D O I：
10.1016/0090-8258(86)90113-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 43
页数：4
相关论文
共 50 条
  • [41] PHASE-II STUDIES OF MITOZOLOMIDE IN MELANOMA, LUNG AND OVARIAN-CANCER
    HARDING, M
    DOCHERTY, V
    MACKIE, R
    DORWARD, A
    KAYE, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05): : 785 - 788
  • [42] PHASE-II TRIAL OF MITOMYCIN-C PLUS 5-FU IN THE TREATMENT OF DRUG-REFRACTORY OVARIAN-CANCER
    ALBERTS, DS
    GARCIAKENDALL, D
    SURWIT, EA
    SEMINARS IN ONCOLOGY, 1988, 15 (03) : 22 - 26
  • [43] PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    SUTTON, GP
    HOMESLEY, HD
    PARK, R
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 309 - 310
  • [44] A PHASE-II STUDY OF BISANTRENE IN RELAPSING OR REFRACTORY ACUTE NONLYMPHOBLASTIC LEUKEMIAS
    ISNARD, F
    MARTY, M
    GISSELBRECHT, C
    ESPIE, M
    MARAL, J
    BOIRON, M
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 122 - 122
  • [45] PHASE-II TRIAL OF BISANTRENE FOR ADVANCED HYPER-NEPHROMA
    SCHER, H
    SCHWARTZ, S
    YAGODA, A
    WATSON, R
    FAYE, L
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1653 - 1655
  • [46] PHASE-II TRIAL OF BISANTRENE IN ADVANCED COLORECTAL-CARCINOMA
    AHMED, T
    KEMENY, NE
    MICHAELSON, RA
    HARPER, HD
    CANCER TREATMENT REPORTS, 1983, 67 (03): : 307 - 308
  • [47] PHASE-II EVALUATION OF BISANTRENE HYDROCHLORIDE IN REFRACTORY MALIGNANT-MELANOMA
    ALBERTS, DS
    MASONLIDDIL, N
    GREEN, SJ
    COWAN, JD
    FLETCHER, WS
    NEILAN, B
    GUY, JT
    EPSTEIN, RB
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (03) : 289 - 292
  • [48] TENIPOSIDE (VM-26) IN PATIENTS WITH ADVANCED REFRACTORY OVARIAN-CANCER - A PHASE-II STUDY OF THE NETHERLANDS JOINT STUDY-GROUP FOR OVARIAN-CANCER
    VANDERBURG, MEL
    HUININK, WWT
    VRIESENDORP, R
    VANOOSTEROM, AT
    NEIJT, JP
    VERMORKEN, JB
    VANPUTTEN, WLJ
    KOOIMAN, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 997 - 998
  • [49] PHASE-II STUDY OF COMBINATION 4'-EPIDOXORUBICIN AND MITOMYCIN-C IN RECURRENT EPITHELIAL OVARIAN-CANCER
    REDMAN, C
    LAWTON, F
    STUART, N
    OBRIEN, M
    BUXTON, J
    MOULD, J
    CHETIYAWARDANA, A
    CRAWFORD, M
    PATTERSON, M
    SYKES, V
    BLACKLEDGE, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (01) : 51 - 53
  • [50] PHASE-II TRIAL OF BISANTRENE FOR METASTATIC MELANOMA - AN ILLINOIS-CANCER-COUNCIL STUDY
    STIFF, PJ
    SWEET, D
    KILTON, LJ
    JOHNSON, CM
    MUNTEAN, B
    BLOUGH, RR
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02): : 126 - 128
12345